Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: An analysis of the Japanese National Research Project on Intractable Diseases database-Reference-Cited by-同舟云学术

Reductions in pulmonary function detected in patients with lymphangioleiomyomatosis: An analysis of the Japanese National Research Project on Intractable Diseases database

Published:2016-05 Issue:3 Volume:54 Page:193-200
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Hayashida Mie,Yasuo Masanori,Hanaoka Masayuki,Seyama Kuniaki,Inoue Yoshikazu,Tatsumi Koichiro,Mishima Michiaki

Funder

Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference28 articles.

1. Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment;Meraj;Semin Respir Crit Care Med,2012

2. Lymphangioleiomyomatosis: what do we know and what are we looking for?;Harari;Eur Respir Rev,2011

3. Management of lymphangioleiomyomatosis;Taveira-DaSilva;F1000Prime Rep,2014

4. Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM);Hammes;Horm Cancer,2013

5. Lymphangioleiomyomatosis—a wolf in sheep׳s clothing;Henske;J Clin Invest,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel developments in the study of estrogen in the pathogenesis and therapeutic intervention of lymphangioleiomyomatosis;Orphanet Journal of Rare Diseases;2024-06-14

2. Lymphangioleiomyomatosis and pregnancy: a mini-review;Archives of Gynecology and Obstetrics;2024-04-09

3. Lymphangioleiomyomatosis and mTOR inhibitors in real world—a narrative review;Journal of Thoracic Disease;2023-11

4. Determinants of Progression and Mortality in Lymphangioleiomyomatosis;CHEST;2023-07

5. Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis;Chest;2023-06